Home > Insider Trading > Filing (0001209191-18-050601)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
818033	Heron Therapeutics Inc.	HRTX	Pharmaceutical Preparations (2834)	942875566

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1178579	C Kevin Tang	4747 Executive Drive Suite 510 San Diego CA 92121	Yes	No	Yes	No
1191935	Tang Capital Partners Lp	4747 Executive Drive, Suite 510 San Diego CA 92121	No	No	Yes	No
1232621	Tang Capital Management Llc	4747 Executive Drive, Suite 510 San Diego CA 92121	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-09-12	2,695,000	$35.75	5,830,215	No	4	S	Indirect	By LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,347	Indirect	As Trustee
Common Stock	6,941	Direct

Footnotes

The Reporting Person's sale of common stock reported herein may be deemed to be matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 192,308 shares of common stock purchased by the Reporting Person on March 29, 2018. The Reporting Person has sent to the Issuer the full amount of the disgorgeable profit arising from the sale reported herein.
The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP.
The securities are held by Kevin C. Tang as custodian for his minor children, as Trustee of the Kevin C. Tang Family Trust, and as Trustee of the Tang Advisors, LLC Profit Sharing Plan.
2,147 of these securities are held by Kevin C. Tang's IRA.